ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
ObvioHealth was asked to conduct an observational study of infant crying and fussing.
Caregivers recorded their infants’ crying/fussing and used the ObvioHealth app to provide feedback on their perception of each event through daily questionnaires and e-diaries. Mandatory training and ongoing communication with subjects minimized user-interface issues and improved data integrity.
Reported crying/fussing frequency and duration was 2-3 times higher than audio-recorded events. Results provided insights into device functionality and human bias.
A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.
A biopharmaceutical company is seeking a Phase IV clinical trial to confirm the safety and efficacy of its ADHD therapeutic on a more real-world population. Phases I-III included narrow inclusion and exclusion criteria.